Adrenal disease

Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening

J Clin Endocrinol MetabPublished Prospective longitudinal cohort study

Authors' conclusion

Measurement of 17OHP by LC-MS/MS provides the best performance for serum confirmatory tests and may be complemented by the (17OHP+Δ4)/cortisol ratio analysis. Genotyping is useful mainly to resolve persistently indeterminate biochemical results.

Study context

Population
Newborns in CAH newborn screening recalled for N17OHP ≥ 2 × 99.5th for serum confirmatory testsnewborns evaluated
Participants
708,437 newborns
Exposure
Serum 17OHP by radioimmunoassay (RIA) vs LC-MS/MS as confirmatory tests after positive CAH newborn screening (NBS)
Outcome
PPV of serum confirmatory tests
Methodological detailsdiagnostic accuracy (ROC curves), Altered hormonal results submitted to CYP21A2 genotyping
  • Diagnostic accuracy (ROC curves)
  • Altered hormonal results submitted to CYP21A2 genotyping

Main finding

As reported in the abstract

Serum 17OHP remained increased; PPV
GroupValuePPV
RIA26%30%
LC-MS/MS11%49%

Value

RIA26%
LC-MS/MS11%

PPV

RIA30%
LC-MS/MS49%

Observational data: associations, not effects.

Further findings

Recall rate of N17OHP (first tier)

Recall rate
0.03%

Diagnoses

Newborns (NBs) diagnosed with classical forms
58
Asymptomatic NBs with persistently increased serum 17OHP
32

ROC: false vs true positives

17OHP/LC-MS/MS highest diagnostic performance; cutoff 48.3 ng/mL (146.3 nmol/L) = 100% sensitivity
(17OHP+Δ4)/cortisol ratio highest discriminative ability; cutoff 24.9 = 100% PPV
Serum 21DF good performance, comparable to 17OHP by LC-MS/MS (99% specificity)

Original publication

Efficacy of Liquid-chromatography and Radioimmunoassay in False-positives’ Drop-off in CAH Newborn Screening. J Clin Endocrinol Metab. Published 11 March 2026. doi:10.1210/clinem/dgag107

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.